BERLIN, Nov 19 (Reuters) - The head of Germany’s Robert Koch Institute (RKI) for infectious diseases said on Thursday recent news on experimental COVID-19 vaccine trials has been extremely encouraging.
“This is of course extremely encouraging, extremely positive news,” Lothar Wieler said at a virtual news conference.
Vaccines with an efficacy of more than 90% would be “great weapons” in the fight against the pandemic, he added. (Reporting by Thomas Seythal and Kirsti Knolle)
Our Standards: The Thomson Reuters Trust Principles.